Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
37%
OVERLAP
BY WEIGHT
8
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
16%
ALSO IN THNR
THNR
18
HOLDINGS
44%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.2% | 12.2% | 8.2% |
|
ABBVIE INC | 7.7% | 5.8% | 5.8% |
|
PFIZER INC | 7.2% | 5.7% | 5.7% |
|
MERCK & CO. INC. | 6.8% | 5.2% | 5.2% |
|
GILEAD SCIENCES INC | 3.9% | 5.9% | 3.9% |
FTXH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 6.9% |
|
BIOGEN IDEC INC | 3.9% |
|
VIATRIS, INC. | 3.9% |
|
UNITED THERAPEUTICS CORP | 3.5% |
|
ZOETIS INC | 3.5% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
|
INCYTE CORP | 3.2% |
|
BRISTOL-MYERS SQUIBB CO | 3.1% |
|
EXELIXIS INC | 2.6% |
 |
JAZZ PHARMACEUTICALS PLC | 2.3% |
FTXH Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.8% |
 |
ASTRAZENECA PLC | -6.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.3% |
|
VIKING THERAPEUTICS, INC. | -4.3% |
|
ELI LILLY & CO | -4.0% |
|
ZEALAND PHARMA A/S | -3.5% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.3% |
 |
HANMI PHARM CO LTD | -2.9% |